+ New Watchlist

Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

Immatics

IMTXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$7.59

0.01000.13%

At close: -

$7.59

00.00%

After Hours: Nov 22, 4:00 PM EDT

Q3 2024 Earnings were released on Mon Nov 18th, before the market open

Immatics (IMTX) Forecast

News

Earnings Immatics (IMTX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Immatics (NASDAQ:IMTX) Stock

Immatics Stock (NASDAQ: IMTX)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, November 19, 2024

B of A Securities Maintains Buy on Immatics, ...
Benzinga Newsdesk

Friday, October 11, 2024

Reported Earlier, Immatics Prices $150M Publi...
Benzinga Newsdesk

Thursday, October 10, 2024

Why Is Cancer-Focused Immatics Stock Trading Lower On Thursday?
Vandana Singh
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Immatics shares are trading lower after the c...
Benzinga Newsdesk
Immatics Plans $150M Public Offering Of Its O...
Benzinga Newsdesk
Immatics Filed For Mixed Shelf Offering; Size...
Benzinga Newsdesk
Immatics Announced Updated Phase 1B Data On A...
Benzinga Newsdesk

Monday, October 07, 2024

Piper Sandler Initiates Coverage On Immatics ...
Benzinga Newsdesk

Monday, September 16, 2024

Immatics Presented The Proof-of-concept Clini...
Benzinga Newsdesk

Monday, September 09, 2024

Cantor Fitzgerald Reiterates Overweight on Im...
Benzinga Newsdesk

Thursday, September 05, 2024

Cantor Fitzgerald Reiterates Overweight on Im...
Benzinga Newsdesk

Thursday, August 15, 2024

AstraZeneca Imfinzi Combo Gets EU Nod for Uterine Cancer
Zacks

Tuesday, August 13, 2024

Immatics Q2 2024 GAAP EPS €(0.17) May Not Be ...
Benzinga Newsdesk

Wednesday, July 31, 2024

United Therapeutics Q2 Earnings Lag, Sales Top Estimates
Zacks

Monday, July 22, 2024

Here's Why 'Trend' Investors Would Love Betting on Immatics
Zacks

Friday, May 24, 2024

12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights

Thursday, May 16, 2024

Mizuho Maintains Buy on Immatics, Raises Pric...
Benzinga Newsdesk

Thursday, March 21, 2024

Immatics shares are trading lower after the c...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Immatics Q4 GAAP EPS €(1.20) Down From €0.55 ...
Benzinga Newsdesk

Monday, March 18, 2024

10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights

Thursday, January 18, 2024

Immatics Prices $175M Public Offering Of 15,9...
Benzinga Newsdesk

Wednesday, January 17, 2024

Immatics Reports Commencement Of Public Offer...
Benzinga Newsdesk

Wednesday, November 08, 2023

Immatics Reports Interim Clinical Data From A...
Benzinga Newsdesk

Thursday, November 02, 2023

Cantor Fitzgerald Initiates Coverage On Immat...
Benzinga Newsdesk

Tuesday, October 24, 2023

Immatics Receives FDA Regenerative Medicine A...
Benzinga Newsdesk

Monday, September 11, 2023

Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics
Charles Gross

Thursday, August 17, 2023

Immatics Q2 EPS $(0.35) Misses $(0.24) Estima...
Benzinga Newsdesk

Thursday, August 10, 2023

Immatics Has Initiated Phase 1/2 Trial With I...
Benzinga Newsdesk

Monday, July 24, 2023

Why Immatics Shares Are Rising Today
Nabaparna Bhattacharya
Immatics shares are trading higher after the ...
Benzinga Newsdesk
Bristol Myers Squibb Has Made A $35 Million E...
Benzinga Newsdesk

Tuesday, June 27, 2023

Immatics Biotechnologies Granted U.S. Patent #11685769: Peptides for use in immunotherapy against cancers
Charles Gross

Thursday, June 22, 2023

Top 5 Health Care Stocks That May Crash This Month
Lisa Levin

Tuesday, June 13, 2023

Immatics Biotechnologies Granted U.S. Patent #11673917: Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers
Charles Gross

Tuesday, May 16, 2023

Recap: Immatics Q1 Earnings
Benzinga Insights
Immatics Biotechnologies Granted U.S. Patent #11648276: Immunotherapy against neuronal and brain tumors; #11648292: Immunotherapy against several tumors including gastrointestinal and gastric cancer
Charles Gross
Immatics' Cash Position Of €329.8M, With Cash...
Benzinga Newsdesk
Immatics Q1 EPS $(0.28) Beats $(0.30) Estimat...
Benzinga Newsdesk

Tuesday, May 02, 2023

12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
What's Going On With Immatics Shares Today
Vandana Singh
US Stocks Down; Chegg Crashes After Removing Guidance On ChatGPT Concerns
Lisa Levin
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Immatics shares are trading higher after the ...
Benzinga Newsdesk
Immatics Reports Interim Clinical Data From O...
Benzinga Newsdesk
Immatics Reported Interim Clinical Data from Ongoing Phase 1b Cohort A Monotherapy With ACTengine IMA203 TCR-T Targeting PRAME
Charles Gross

Monday, May 01, 2023

Bristol-Myers Squibb's Breyanzi Aces Two Lymphoma Studies On Overall Response Rate Endpoint, Plus New Collaboration
Vandana Singh
Bristol Myers Squibb Has Exercised Its Option...
Benzinga Newsdesk

Friday, March 31, 2023

Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023
Benzinga Insights

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved